Skip to main navigation Skip to search Skip to main content

Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries

  • Roberto Rodríguez-Rivas
  • , Ana Flisser
  • , Luiz Fernando Norcia
  • , Pedro Tadao Hamamoto Filho
  • , D. Katterine Bonilla-Aldana
  • , Alfonso J. Rodriguez-Morales
  • , Arturo Carpio
  • , Matthew L. Romo
  • , Agnès Fleury
  • Instituto Nacional de Neurologia y Neurocirugia
  • Universidad Nacional Autónoma de México
  • Universidade Estadual Paulista Júlio de Mesquita Filho
  • Fundación Universitaria Autónoma de las Américas
  • Universidad Científica del Sur
  • Universidad de Cuenca
  • City University of New York

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Background Neurocysticercosis (NC) is one of the major parasitic diseases affecting the central nervous system and is endemic in much of Asia, sub-Saharan Africa, and Latin America. Its epidemiology is difficult to assess, although official registries are available in Brazil, Colombia, Ecuador, and Mexico. Methodology/Principal findings Using official statistics, we assessed trends in NC hospitalization rates during 1998–2019 in Brazil and Ecuador, during 2004–2019 in Mexico, and during 2009–2019 in Colombia. We also assessed the trend in NC mortality in Brazil (1998–2019), the trend in hospitalizations for NC in a Mexican tertiary-level hospital (Instituto Nacional de Neurología y Neurocirugía [INNN]; 1995–2019), and in Mexican primary care ambulatory clinics (1995–2019). Associations between NC hospitalization rates and the human development index (HDI) were also examined. In Brazil, Ecuador, and Mexico, statistically significant decreases in NC hospitalization rates were observed. In Mexico, a significant increase in the age of patients at INNN was observed, suggesting a decreasing incidence of recent infection. Conversely, a significant increase in NC hospitalization rate was observed in Colombia. HDI was not significantly associated with NC hospitalization rates when adjusting for time. Conclusions The downward trends in NC cases in Brazil, Ecuador, and Mexico are encouraging, especially in the context of the PAHO/WHO plan of action to eliminate neglected tropical diseases from the region. On the other hand, in Colombia, the increased NC hospitalization rate is concerning and needs further evaluation so that the authorities can take specific measures. These results should encourage health authorities in other endemic countries to establish a system of official registries to identify where the need for a control program is most urgent. However, it is also important to remember that NC persists, although less frequently in some Latin American countries, and efforts to achieve its control must continue.

Original languageEnglish
Article numbere0010652
JournalPLoS Neglected Tropical Diseases
Volume16
Issue number8
DOIs
StatePublished - 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries'. Together they form a unique fingerprint.

Cite this